Literature DB >> 25052731

The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines.

K Lois1, J Bukowczan, P Perros, S Jones, M Gunn, R A James.   

Abstract

INTRODUCTION: Acromegaly is a chronic, debilitating and disfiguring condition with a significantly increased morbidity and mortality due to cardiovascular, as well as respiratory complications. Patients with acromegaly are usually diagnosed at the age of 40, however, the duration of symptoms can vary from 5 to 10 years before the formal diagnosis is confirmed. Recent advances in the field of acromegaly have improved survival significantly. A strong association between acromegaly and premalignant colonic lesions and colon cancer has been highlighted. Furthermore, patients with acromegaly have a greater lifetime risk of malignant transformation and a far worse overall prognosis from colorectal cancer, which is now considered a major disease related complication.
MATERIALS AND METHODS: A comprehensive search strategy was applied for the Medline/PubMed electronic database from its inception until April 2014. We considered all human research articles published in English, not classified as case report, editorial, comment, letter, or news.
CONCLUSION: Specific recommendations for large bowel endoscopic screening in patients with acromegaly have been proposed. In this comprehensive review we discuss the current state of knowledge and evidence on colonoscopic screening in patients with acromegaly illustrated by a case of aggressive colorectal cancer presenting late in a young woman with difficult to control acromegaly.

Entities:  

Mesh:

Year:  2015        PMID: 25052731     DOI: 10.1007/s11102-014-0586-5

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  50 in total

Review 1.  Clinical review 18: Are patients with acromegaly at increased risk for neoplasia?

Authors:  S Ezzat; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1991-02       Impact factor: 5.958

2.  Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly.

Authors:  P J Jenkins; V Frajese; A M Jones; C Camacho-Hubner; D G Lowe; P D Fairclough; S L Chew; A B Grossman; J P Monson; G M Besser
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.

Authors:  Laurence Katznelson; John L D Atkinson; David M Cook; Shereen Z Ezzat; Amir H Hamrahian; Karen K Miller
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

4.  Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.

Authors:  Thomas J W Lee; Matthew D Rutter; Roger G Blanks; Sue M Moss; Andrew F Goddard; Andrew Chilton; Claire Nickerson; Richard J Q McNally; Julietta Patnick; Colin J Rees
Journal:  Gut       Date:  2011-09-22       Impact factor: 23.059

Review 5.  Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis.

Authors:  Perry J Pickhardt; Cesare Hassan; Steve Halligan; Riccardo Marmo
Journal:  Radiology       Date:  2011-03-17       Impact factor: 11.105

6.  The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients.

Authors:  B Delhougne; C Deneux; R Abs; P Chanson; H Fierens; P Laurent-Puig; I Duysburgh; A Stevenaert; A Tabarin; J Delwaide; G Schaison; J Belaïche; A Beckers
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

Review 7.  Current treatment guidelines for acromegaly.

Authors:  S Melmed; I Jackson; D Kleinberg; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

8.  Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop.

Authors:  H Lahm; P Amstad; J Wyniger; A Yilmaz; J R Fischer; M Schreyer; J C Givel
Journal:  Int J Cancer       Date:  1994-08-01       Impact factor: 7.396

9.  Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).

Authors:  Alberto Fernandez; Niki Karavitaki; John A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2009-07-24       Impact factor: 3.478

10.  Increased epithelial cell proliferation in the colon of patients with acromegaly.

Authors:  A Cats; R P Dullaart; J H Kleibeuker; F Kuipers; W J Sluiter; M J Hardonk; E G de Vries
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

View more
  12 in total

Review 1.  Complications of acromegaly: thyroid and colon.

Authors:  Amit Tirosh; Ilan Shimon
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  Excess growth hormone suppresses DNA damage repair in epithelial cells.

Authors:  Vera Chesnokova; Svetlana Zonis; Robert Barrett; Hiraku Kameda; Kolja Wawrowsky; Anat Ben-Shlomo; Masaaki Yamamoto; John Gleeson; Catherine Bresee; Vera Gorbunova; Shlomo Melmed
Journal:  JCI Insight       Date:  2019-02-07

Review 3.  Acromegaly and Colorectal Neoplasm: An Update.

Authors:  Leandro Kasuki; Bernardo Maia; Mônica R Gadelha
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-20       Impact factor: 6.055

4.  Growth hormone is permissive for neoplastic colon growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Cuiqi Zhou; Maria Victoria Recouvreux; Anat Ben-Shlomo; Takako Araki; Robert Barrett; Michael Workman; Kolja Wawrowsky; Vladimir A Ljubimov; Magdalena Uhart; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-25       Impact factor: 11.205

Review 5.  [Diagnostics and treatment of acromegaly : Necessity for targeted monitoring of comorbidities].

Authors:  S Petersenn; M Christ-Crain; M Droste; R Finke; J Flitsch; I Kreitschmann-Andermahr; A Luger; J Schopohl; G Stalla
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

Review 6.  Challenges in the diagnosis and management of acromegaly: a focus on comorbidities.

Authors:  Alin Abreu; Alejandro Pinzón Tovar; Rafael Castellanos; Alex Valenzuela; Claudia Milena Gómez Giraldo; Alejandro Castellanos Pinedo; Doly Pantoja Guerrero; Carlos Alfonso Builes Barrera; Humberto Ignacio Franco; Antônio Ribeiro-Oliveira; Lucio Vilar; Raquel S Jallad; Felipe Gaia Duarte; Mônica Gadelha; Cesar Luiz Boguszewski; Julio Abucham; Luciana A Naves; Nina Rosa C Musolino; Maria Estela Justamante de Faria; Ciliana Rossato; Marcello D Bronstein
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

7.  Patients with Acromegaly Presenting with Colon Cancer: A Case Series.

Authors:  Murray B Gordon; Samer Nakhle; William H Ludlam
Journal:  Case Rep Endocrinol       Date:  2016-11-29

Review 8.  A Consensus Statement on acromegaly therapeutic outcomes.

Authors:  Shlomo Melmed; Marcello D Bronstein; Philippe Chanson; Anne Klibanski; Felipe F Casanueva; John A H Wass; Christian J Strasburger; Anton Luger; David R Clemmons; Andrea Giustina
Journal:  Nat Rev Endocrinol       Date:  2018-09       Impact factor: 43.330

Review 9.  Pasireotide: a novel treatment for patients with acromegaly.

Authors:  Daniel Cuevas-Ramos; Maria Fleseriu
Journal:  Drug Des Devel Ther       Date:  2016-01-11       Impact factor: 4.162

10.  Prevalence of colonic polyp and its predictors in patients with acromegaly.

Authors:  Purnima Agarwal; Praveer Rai; Manoj Jain; Shambhavi Mishra; Uttam Singh; Sushil Kumar Gupta
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.